Nalgosed, 10mg/ml, Solution for injection
Nalgosed, 10mg/ml, Solution for injection
Authorised
- Butorphanol
Product identification
Medicine name:
Nalgosed 10mg/ml ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Nalgosed, 10mg/ml, Solution for injection
Active substance:
- Butorphanol
Target species:
-
Cat
-
Dog
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Butorphanol10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cat
-
Dog
-
-
Intravenous use
-
Horse
-
Milk0day
-
Meat and offal0day
-
-
Cat
-
Dog
-
-
Subcutaneous use
-
Cat
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN02AF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Glass Vial 1 x 10.0 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 74783/04-08-2021/K-0232301
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0142/001
Concerned member states:
-
Bulgaria
-
Estonia
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
